Profile Picture
Rewards
  • All
  • Chat
  • Images
  • Videos
  • Maps
  • News
  • More
    • Shopping
    • Flights
    • Travel
    • Hotels
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business

Trending on Bing

Spark marriage rumors
Knocks out Heat mascot
Kaczynski dies in prison
Massive sinkhole in Fla.
‘Vampire’ remains found
Robert Bell dies at 79
Harassed at airport?
Trump to speak in Georgia
'Autopilot' crash toll
Rare statue on auction
Recalled over racist slur
Dermody cut by Red Sox
Kansas City shooting
Russian strikes kill 3
UKR closes nuclear plant
BART to increase fares
US Havana embassy facelift
Sushi chain sues student
Canadian PM visits Kyiv
Wins 3rd French Open
New 'Leprechaun' film
Boston Pride parade returns
$500M opioid settlement
To skip Sunday blessing
Indonesia deports surfer
Tony Awards 2023
R.I. $14B budget approved
$45M in Randy Cox case
Biden marks Pride Month
US Open'23
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
28,200 results
U.S. News & World Report18d
FDA Approves New Nasal Spray to Reverse Overdoses
"On the heels of the FDA's recent approval of the first over-the-counter opioid reversal agent [Narcan], the availability of nalmefene nasal spray places a new prescription opioid reversal option ...
UPI18d
FDA approves Opvee nasal spray to reverse opioid overdose
"On the heels of the FDA's recent approval of the first over-the-counter opioid reversal agent [Narcan], the availability of nalmefene nasal spray places a new prescription opioid reversal option ...
STAT19d
New nasal spray to reverse fentanyl and other opioid overdoses gets FDA approval
“We’re not suffering from a naloxone shortage where we need to use an alternative,” he said. “We have plenty of it and it works perfectly well.” The FDA approval comes as drug overdose ...
Reuters18d
US FDA approves Opiant's spray for reversing opioid-related overdoses
Signage is seen outside of the Food and Drug Administration (FDA) headquarters ... on Monday approved Opiant Pharmaceuticals Inc's nasal spray for reversing opioid-related overdoses, expanding ...
11d
FDA Approves Extended-Release Injection for Opioid Use Disorder
The U.S. Food and Drug Administration has approved Brixadi (buprenorphine) extended-release injection to treat ...
Time18d
FDA Approves New Nasal Spray to Reverse Opioid Overdoses
“We’re not suffering from a naloxone shortage where we need to use an alternative,” he said. “We have plenty of it and it works perfectly well.” The FDA approval comes as drug overdose ...
The Hill18d
FDA approves prescription nasal spray to reverse opioid overdoses
The Food and Drug Administration (FDA) approved a prescription nasal spray this week that can reverse opioid overdoses. Opvee is an almefene hydrochloride nasal spray that is the first of its kind ...
High Times16d
FDA Approves Nasal Spray To Reverse Fentanyl Overdoses
Califf said in Monday’s announcement. “On the heels of the FDA’s recent approval of the first over-the-counter opioid reversal agent, the availability of nalmefene nasal spray places a new ...
Oklahoma's News18d
FDA approves prescription nasal spray to reverse opioid overdoses
(The Hill) — The Food and Drug Administration (FDA) approved a prescription nasal spray this week that can reverse opioid overdoses. Opvee is an almefene hydrochloride nasal spray that is the ...
AOL18d
FDA approves prescription nasal spray to reverse opioid overdoses
The FDA said that if the product is… Opvee is an almefene hydrochloride nasal spray that is the first of its kind to be used to treat opioid overdoses in adults and children over the age of 12.
WGNO18d
FDA approves prescription nasal spray to reverse opioid overdoses
(The Hill) — The Food and Drug Administration (FDA) approved a prescription nasal spray this week that can reverse opioid overdoses. Opvee is an almefene hydrochloride nasal spray that is the ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
© 2023 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback